Top

Current Fungal Infection Reports

Published in:

01-12-2019 | Candidiasis | Pediatric Fungal Infections (D Corzo-Leon, Section Editor)

AIDS-Related Mycoses in the Paediatric Population

Authors: B. E. Ekeng, O. O. Olusoga, R. O. Oladele

Published in: Current Fungal Infection Reports | Issue 4/2019

Abstract

Purpose of Review

Fungal infections account for significant morbidity and mortality in HIV-infected children particularly in developing countries where there is lack of skilled personnel and infrastructure to make the appropriate diagnosis. This is further compounded by poor availability and accessibility of the antifungals needed to treat these infections. The purpose of this review is to highlight the paucity of data on AIDS-related mycoses in the paediatric age group and make appropriate recommendations to address challenges associated with mycoses in this population.

Recent Findings

These infections are categorised in two broad groups in this population: mucocutaneous, which commonly affects nutrition and adherence to therapy and invasive fungal infections which are life-threatening. A literature search revealed a total of 29 published literatures across all AIDS-related mycoses in the paediatric population.

Summary

Research to determine the true burden of the problem and greater funding with implementation of a package of care that will result in substantial reductions in morbidity and mortality in relation to AIDS-related mycoses in children are needed. It is imperative that the programmatic optimal package of care for children with advanced HIV disease is designed and implemented.

• Ford N, Meintjes G, Calmy A, Bygrave H, Migone C, Vitoria M, et al. Managing advanced HIV disease in a public health approach. Clin Infect Dis. 2018;66(S2):S106–10 This is a review article that highlights the challenges of opportunistic infections with advanced HIV disease.PubMedPubMedCentral

•• Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy, July 2017. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. This is the current guidelines for diagnosing, therapeutic and preventive management of opportunistic infections in advanced HIV disease.

Armstrong-James D, Meintjes G, Brown GD. A neglected epidemic: Fungal infections in HIV/AIDS. Trends Microbiol. 2014;22(3).PubMed

Marques SA, Robles AM, Tortorano AM, Tuculet MA, Negroni R, Mendes RP. Mycoses associated with AIDS in the Third World. Med Mycol. 2000;38(Supplement 1):269–79.PubMed

•• Frigati L, Archary M, Rabie H, Penazzato M, Ford N. Priorities for decreasing morbidity and mortality in children with advanced HIV disease. Clin Infect Dis. 2018;66(S2):S147–S51 Very important review highlighting the knowledge gaps, offering possible solutions and challenging the status quo. PubMedPubMedCentral

Brown GD, Meintjes G, Kolls JK, Gray C, Horsnell W. AIDS-related mycoses: the way forward. Trends Microbiol. 2014;22(3):107–9. https://doi.org/10.1016/j.tim.2013.12.008.CrossRefPubMedPubMedCentral

King J, Pana Z, Lehrnbecher T, Steinbach WJ, Warris A. Recognition and clinical presentation of invasive fungal disease in neonates and children. Journal of the Paediatric Infectious Diseases Society. 2017;6(S1):S12–21.

Katragkou A, Fisher BT, Groll AH, Roilides E, Walsh TJ. Diagnostic imaging and invasive fungal diseases in children. J Paediatr Infect Dis Soc. 2017;6(1):S22–31. https://doi.org/10.1093/jpids/pix055.CrossRef

Seth R, Xess I, Jana M. Diagnosis of invasive fungal infections in children. Indian Paediatr. 2019;56.PubMed

10.

Mendiratta V, Mittal S, Jain A, Chande R. Mucocutaneous manifestations in children with human immunodeficiency virus infection. Indian Journal of Dermatology, Venereology and Leprol. 2010;76:458–66. https://doi.org/10.4103/0378-6323.69041.CrossRef

11.

Sing Y, Govender D. Infections in the HIV-infected child. Diagn Histopathol. 2009;15(5):251–63.

12.

Gona P, Van Dyke RB, Williams PL, et al. Incidence of opportunistic and other infections in HIV-infected children in the HAART era. J Am Med Assoc. 2006;296(3):292–300.

13.

Chiou CC, Groll AH, Mavrogiorgos N, Wood LV, Walsh TJ. Esophageal candidiasis in human immunodeficiency virus-infected pediatric patients after the introduction of highly active antiretroviral therapy. Paediatr Infect Dis J. 2002;21(5):388–92.

14.

Walsh TJ, Gonzalez C, Roilides E, et al. Fungemia in children infected with the human immunodeficiency virus: new epidemiologic patterns, emerging pathogens, and improved outcome with antifungal therapy. Clin Infect Dis. 1995;20(4):900–6.PubMed

15.

Dankner WM, Lindsey JC, Levin MJ, Paediatric ACTGPT. Correlates of opportunistic infections in children infected with the human immunodeficiency virus managed before highly active antiretroviral therapy. Paediatr Infect Dis J. 2001;20(1):40–8.

16.

Leibovitz E, Rigaud M, Chandwani S, et al. Disseminated fungal infections in children infected with human immunodeficiency virus. Paediatr Infect Dis J. 1991;10(12):888–94.

17.

Gonzalez CE, Venzon D, Lee S, Mueller BU, Pizzo PA, Walsh TJ. Risk factors for fungemia in children infected with human immunodeficiency virus: a case-control study. Clin Infect Dis. 1996;23(3):515–21.PubMed

18.

Wasserman S, Engel ME, Griesel R, Mendelson M. Burden of pneumocystis pneumonia in HIV-infected adults in sub-Saharan Africa: a systemic review and meta-analysis. BMC Infetious Diseases. 2016;16(1):482.

19.

Walzer PD, Evans HE, Copas AJ, Edwards SG, Grant AD, Miller RF. Early predictors of mortality from Pneumocystis jirovecii pneumonia in HIV-infected patients: 1985–2006. Clin Infect Dis. 2008;46:625–33.PubMedPubMedCentral

20.

Elvin KM, Lumbwe CM, Luo NP, Bjorkman A, Kallenius G, Linder E. Pneumocystis carinii is not a major cause of pneumonia in HIV infected persons in Lusaka, Zambia. Tropical Med Hygiene. 1989;83(4):553–555s.

21.

Abouya YL, Beaumel A, Lucas S, Dago-Akribi A, Coulibaly G, Konan JB, et al. Pneumocystis carinii pneumonia. An uncommon cause of death in African patients with acquired immunodeficiency syndrome. American Review of Respiratory Disease returns. 1992;145(3):617–201992.

22.

Mayer KH, Fisk DT, Meshnick S, Kazanjian PH. Pneumocystis carinii pneumonia in patients in the developing world who have acquired immunodeficiency syndrome. Clin Infect Dis. 2003;36(1):70–8.

23.

Morris A, Lundgren JD, Masur H, Walzer PD, Hanson DL, Frederick T, et al. Current epidemiology of pneumocystis pneumonia. Emerg Infect Dis. 2004;10(10):1713–20.PubMedPubMedCentral

24.

Lucas S, Goodgame R, Kocjan G, Serwadda D. Absence of Pneumocystosis in Ugandian AIDS patients. AIDS. 1989;3(1):47–8.PubMed

25.

Karstaedt AS. AIDS-the Baragwanath experience. Part 111. HIV infection in adults at Baragwanath Hospital. South African Med. 1992;82(2):95–7.

26.

Carme B, Mboussa J, Andzin, Mbouni E, Mpele P, Datry A. Pneumocystis carinii is rare in AIDS in Central Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1991;85(1):80.PubMed

27.

Lucas SB, Odida M, Wabinga H. The pathology of severe morbidity and mortality caused by HIV infection in Africa. AIDS. 1991;5:S143.PubMed

28.

Atzori C, Bruno A, Chichino G, Gatti S, Scaglia M. Pneumocystis carinii pneumonia and tuberculosis in Tanzanian patients infected with HIV. Trans R Soc Trop Med Hyg. 1993;87(1):55–6.PubMed

29.

Malin AS, Gwanzura LKZ, Robertson VJ, Musvaire P, Mason PR, Klein S. Pneumocystis carinii pneumonia in Zimbabwe. Lancet. 1995;346(8985):1258–61.PubMed

30.

31.

Norton KI, Kattan M, Rao JS, Cleveland R, Trautwein L, Mellins RB, et al. Chronic radiographic lung changes in children with vertically transmitted HIV-1 infection. Am J Roentgenol. 2001;18;176(6):1553–8.

32.

Nathoo K, Gondo M, Gwanzura L, Mhlanga B, Mavetera T, Mason P. Fatal Pneumocystis carinii pneumonia in HIV-seropositive infants in Harare, Zimbabwe. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2001;95:37–9. https://doi.org/10.1016/S0035-9203(01)90325-6.CrossRefPubMed

33.

Lucas SB, Peacock CS, Hounnou A, et al. Disease in children infected with HIV in Abidjan Cote d’voire. Br Med J. 1996;312:335–8.

34.

Ansari NA, Kombe AH, Kenyon TA, Mazhani L, Binkin N, Tappero JW, et al. Pathology and causes of death in a series of human immunodeficiency virus-positive and -negative pediatric referral hospital admissions in Botswana. Pediatr Infect Dis J. 2003;22:43–7 Vol. 22, No. 1.PubMed

35.

Masur H, Kaplan JE, Holmes KK. Guidelines for preventing opportunistic infections among HIV-infected persons—2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. In: The Morbidity and Mortality Weekly Report Recommendations and Reports; 2002, Jun 12:51(RR-8). p. 1–52.

36.

Vargas SL, Huges WT, Santolaya ME, Ulloa AV, Ponce CA, Cabrera CE, et al. Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants. Clin Infect Dis. 2001;32(6):855–61.PubMed

37.

Lanaspa M, Callaghan-Gordo CO, Machevo S, Madrid L, Nhampossa T, Acácio S, et al. High prevalence of Pneumocystis jirovecii pneumonia among Mozambican children < 5 years of age admitted to hospital with clinical severe pneumonia, Clinical Microbiology and Infection. 2015;21:1018.e9–1018.e15. https://doi.org/10.1016/j.cmi.2015.07.011.PubMed

38.

• Lowe DM, Rangaka MX, Gordon F, James CD, et al. Pneumocystis jirovecii pneumonia in tropical and low and middle income countries: a systemic review and meta-regression. Plos one. 2013;8(8):e69969 This systematic review is focussed on resource-limited settings where the highest burden of advanced HIV disease is and it addresses PCP which is an AIDS defining infection. PubMedPubMedCentral

39.

•• Panel on Opportunistic Infections in HIV-Exposed and HIV-Infected Children. Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children. Department of Health and Human Services. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/oi_guidelines_pediatrics.pdf. This panel focussed exclusively on OIs in advanced HIV disease in children; it proffers evidenced-based guidelines for management.

40.

Oren I, Hardak E, Finkelstein R, Yigla M, Sprecher H. Polymerase chain reaction-based detection of Pneumocystis jirovecii in bronchoalveolar lavage fluid for the diagnosis of pneumocystis pneumonia. Am J Med Sci. 2011;342:182–5.PubMed

41.

Onishi A, Sugiyama D, et. al. Diagnostic accuracy of serum 1,3-beta-D-glucan for pneumocystis jirovecii pneumonia, invasive candidiasis, and invasive aspergillosis: systemic review and meta-analysis. J Clin Microbiol2012;50(1), 7-15

42.

Smith PB, et al. Quantification of 1,3-beta-d-glucan levels in children: preliminary data for diagnostic use of beta-glucan assay in a paediatric setting. Clin Vaccine Immunol. 2007;14:924–5.PubMedPubMedCentral

43.

Jay Koll AIDS mycoses meeting, Cape Town, 2019

44.

• Meiring ST, Quan VC, Cohen C, Dawood H, Karstaedt AS, McCarthy KM, et al. A comparison of cases of paediatric-onset and adult-onset cryptococcosis detected through population-based surveillance, 2005–2007. AIDS 2012, 26:2307–2314. This study highlights the low rates of cryptococcosis in the paediatric population. PubMed

45.

Anígilájé EA, Olutola A, Dabit O, Adeoti AO, Emebolu AJ, et al. There is no cryptococcal antigenaemia among a cohort of children with advanced HIV infection in an antiretroviral therapy programme in Makurdi, Nigeria. J AIDS Clin Res. 2013;4:261. https://doi.org/10.4172/2155-6113.1000261.CrossRef

46.

Ezeanolue EE, Nwizu C, Greene GS, Amusu O, Chukwuka C, Ndembi N, et al. Geographical variation in prevalence of cryptococcal antigenemia among HIV-infected treatment-naïve patients in Nigeria: a multicenter cross-sectional study. Journal of acquired immune deficiency syndromes. 2016;1;73(1):117.

47.

French N, Gray K, Watera C, Nakiyingi J, Lugada E, Moore M, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS. 2002;16(7):1031–8.PubMed

48.

Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an update analysis. Lancet. 2017;17(8):873–81.PubMed

49.

Nacher M, Adenis A, Blanchet D, Vantilcke V, Demar M, Basurko C, et al. Risk factors for disseminated histoplasmosis in a cohort of HIV-infected patients in French Guiana. PLoS Negl Trop Dis. 2014;30;8(1):e2638. https://doi.org/10.1371/journal.pntd.0002638.CrossRef

50.

Whitt SP, Koch GA, Fender B, Ratnasamy N, Everett ED. Histoplasmosis in pregnancy: case series and report of transplacental transmission. Arch Intern Med. 2004;164(4):454–8.PubMed

51.

L´opez LF, Valencia Y, Tob´on AM, Vel´asquez O, Santa CD, C´aceres DH. Childhood histoplasmosis in Colombia: clinical and laboratory observations of 45 patients. Med Mycol. 2016;54:677–83. https://doi.org/10.1093/mmy/myw020.CrossRef

52.

Pillay T, Pillay DG, Bramdev A. Disseminated histoplasmosis in a human immunodeficiency virus-infected African child. Paediatr Infect Dis J. 1997;16(4):417–8.

53.

Oladele RO, Ayanlowo OO, Richardson MD, Denning DW. Histoplasmosis in Africa: an emerging or a neglected disease? PLoS Negl Trop Dis. 2018;12(1):e0006046. https://doi.org/10.1371/journal.pntd.0006046.PubMedPubMedCentral

54.

Thanha NT, Vinhb LD, Liemb NT, Shikumad C, Daya JN, Thwaitesa G et. al. Clinical features of three patients with paradoxical immune reconstitution inflammatory syndrome associated with Talaromyces marneffei infection. Medical Mycology Case Reports. 2018;19;33–37PubMed

55.

Thuy Le, Kinh N.V, Ngo T.K, Tung N.L.N., Lam N. T. Thuy P.T.T. et. al. A Trial of Itraconazole or Amphotericin B for HIV-Associated Talaromycosis. New England Journal of Medicine, 2017;376:2329-40. https://doi.org/10.1056/NEJMoa1613306.PubMed

56.

Sirisanthana V, Sirisanthana T. Disseminated Penicillium marneffei infection in human immunodeficiency virus-infected children. Paediatr Infect Dis J. 1995 Nov 1;14(11):935–9.

57.

Lee PPW, Chan K-W, Lee T, Hok-Kung Ho M, Chen X, Li C-H, et al. Penicilliosis in children without HIV infection—are they immunodeficient? Clin Infect Dis. 2012;54(2):e8–e19.PubMed

58.

Graham SM, Mankhambo L, Phiri A, Kaunda S, Chikaonda T, Mukaka M, et. al. Impact of Human Immunodeficiency Virus Infection on the Etiology and Outcome of Severe Pneumonia in Malawian Children. The Pediatric Infectious Disease Journal. 2011;30(1).PubMed

59.

Hurtado JC, Castillo P, Fernandes F, Navarro M, Lovane L, Casas I, et al. Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study. Sci Rep. 2019;9:7493–10. https://doi.org/10.1038/s41598-019-43941-w.CrossRefPubMedPubMedCentral

60.

Severo CB, Xavier MO, Gazzoni AF, Severo LC. Cryptococcosis in children. Paediatr Respir Rev. 2009 Dec 1;10(4):166–71.PubMed

61.

Cherian T, Ramakrishna B, Babu PG, John TJ, Raghupathy P. Pneumocystis carinii pneumonia in pediatric acquired immuno-deficiency syndrome. Indian Paediatr, Vol. 1997:34.

62.

Liauw F, Kresnawati W, Kaswandani N. Successful empirical treatment of severe Pneumocystis carinii pneumonia in Immunocompromised Children. American Journal of Medical Case Reports. 2016;4(6):208–11. https://doi.org/10.12691/ajmcr-4-6-6.CrossRef

63.

Fattia GL, Zarb HJ, Swinglerb GH. Clinical indicators of Pneumocystis jiroveci pneumonia (PCP) in South African children infected with the human immunodeficiency virus. Int J Infect Dis. 2006;10:282–5.

64.

Abadi J, Nachman S, Kressel A. B. Cryptococcosis in children with AIDS. Clin Infect Dis. 1999;28:309–13.PubMed

65.

Lizarazo J, Escandón P, Agudelo CI, Castañeda E. Cryptococcosis in Colombian children and literature review. Mem Inst Oswaldo Cruz. 2014 Sep;109(6):797–804.PubMedPubMedCentral

66.

Gonzalez CE, Shetty D, Lewis LL, Mueller BU, Pizzo PA, Walsh TJ. Cryptococcosis in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1996 Sep;15(9):796–800.PubMed

67.

Leggiadro RJ, Kline MW, Hughes WT. Extrapulmonary cryptococcosis in children with acquired immunodeficiency syndrome. Pediatr Infect Dis J. 1991;10:658–62.PubMed

68.

Likasitwattanakul S, Poneprasert SB, Sirisanthana V. Cryptococcosis in HIV-infected children. Southeast Asian J Trop Med Public Health. 2004;35:935–9.PubMed

69.

Joshi NS, Fisher BT, Prasad PA, Zaoutis TE. Epidemiology of cryptococcal infection in hospitalized children. Pediatr Infect Dis J. 2010;29:e91–5.PubMed

70.

Crump JA, Ranadhani HO, Morrissey AB, Saganda W, Mwako MS, Yang LY, et al. Invasive funfal and bacterial infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania. Clin Infect Dis. 2011;1:52(3):341–8. https://doi.org/10.1093/cid/ciq103.CrossRefPubMed

71.

Mosam A, Moodley V, Ramdial PK, Sathar N, Aboobaker J, Singh S. Persistent pyrexia and plaques: a perplexing puzzle. Lancet (London, England). Elsevier. 2006;368:551.

72.

Pamnani R, Rajab J, Githang’a J, Kasmani R. Disseminated histoplasmosis diagnosed on bone marrow aspirate cytology: report of four cases. East Afr Med J. Kenya Med Assoc. 2010;86:102–5. https://doi.org/10.4314/eamj.v86i12.62918.CrossRef

73.

Alverson B, Alexander N, LeGolvan MP, Dunlap W, Levy C. A human immunodeficiency virus-positive infant with probable congenital histoplasmosis in a nonendemic area. Paediatr Infect Dis J. 2010;29(11):1055–7.

74.

Connelly MB, Zerella JT. Surgical management of coccidioidomycosis in children. Journal of Paediatric Surgery. 2000 Nov 1;35(11):1633–4.

75.

Ampel NM, Dols CL, Galgiani JN. Coccidioidomycosis during human immunodeficiency virus infection: results of a prospective study in a coccidioidal endemic area. American Journal of Medicine. 1993;94(4):235–40.PubMed

76.

Bronnimann DA, Adam RD, Galgiani JN, Habib MP, Petersen EA, Porter BEA, et al. Coccidioidomycosis in the acquired immunodeficiency syndrome. Ann Intern Med. 1987;106:372–9.PubMed

77.

Hyatt HW Sr. Coccidioidomycosis in a 3-week-old infant. American Journal of Diseases of Children. 1963;105:93–8.PubMed

78.

Connelly MB, Zerella JT. Surgical management of coccidioidomycosis in children. Journal of Paediatric Surgery. 2000 Nov 1;35(11):1633–4.

79.

Chakrabarti A, Bonifaz A, Gutierrez-Galhardo MC, Mochizuki T, Li S. Global epidemiology of sporotrichosis. Med Mycol. 2015;53(1):3–14. https://doi.org/10.1093/mmy/myuo62.CrossRefPubMed

80.

Bonifaz A, Tirado-Sánchez A. Cutaneous disseminated and extracutaneous sporotrichosis: current status of a complex disease. J Fungi. 2017;3(1):6.

81.

Callens SF, Kitetele F, Lukun P, Lelo P, Van Rie A, Behets F, et al. Pulmonary sporothrix schenckii infection in a HIV positive child. J Trop Pediatr. 2005 Nov 16;52(2):144–6.PubMed

82.

Falci DR, Pasqual;tto AC. Clinical mycology in Latin America and the Caribbean: A snapshot of diagnostic and therapeutic capabilities. Mycoses. 2019: 62(4), 368-373.PubMed

Title: AIDS-Related Mycoses in the Paediatric Population
Authors: B. E. Ekeng
O. O. Olusoga
R. O. Oladele
Publication date: 01-12-2019
Publisher: Springer US
Keywords: Candidiasis
Candidiasis
Cryptococcosis
Human Immunodeficiency Virus
Histoplasmosis
Acquired Immune Deficiency Syndrome
Published in: Current Fungal Infection Reports / Issue 4/2019
Print ISSN: 1936-3761
Electronic ISSN: 1936-377X
DOI: https://doi.org/10.1007/s12281-019-00352-8

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

Illustration of figure on mountain summit/© Orapun / Stock.adobe.com, STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Purpose of Review

Recent Findings

Summary

Please log in to get access to this content

Other articles of this Issue 4/2019

The Manaus Declaration: Current Situation of Histoplasmosis in the Americas, Report of the II Regional Meeting of the International Histoplasmosis Advocacy Group

Update of Vulvovaginal Candidiasis in Pregnant and Non-pregnant Patients

Fungal Necrotizing Skin and Soft Tissue Infections

The Use of Whole Genome and Next-Generation Sequencing in the Diagnosis of Invasive Fungal Disease

Chromoblastomycosis in Solid Organ Transplant Recipients

Pityriasis Versicolor in Children and Adolescents: an Update

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage